Pharmaceutical

Rhelion Life Sciences’ Wholly Owned Subsidiary Filament Health Expands Supply Agreement with the University of Chieti-Pescara for PEX010 in the TEMPO Clinical Trial of Psilocybin for Treatment-Resistant Depression in Italy

As Microdosing Culture Grows, Sacred Connection Introduces Amazonian Grounding Botanicals to Solve Modern “Heady” Burnout

Addressing the growing demand for non-psychedelic micro-rituals, Sacred Connection bridges ancestral Amazonian preparations with North America's microdosing and flow-state communities....

Aetna Expands Bundled Oncology Prior Authorizations, Easing Provider Burden and Accelerating Member Access to Care

Oncology bundling to support all eligible Medicaid members for all cancer typesFull roll-out across all Aetna businesses in 2027Originally published...

Medical Care Technologies Inc. (OTCID:MDCE) Reports Debt-Free Balance Sheet Alongside Continued StrainScan Pro Demos and Melanoma Scan Beta Review

Clean Balance-Sheet Milestone Reached While Melanoma Scan Beta, Wound Care Development, StrainScan Pro Demos and Subsidiary Operations Continue to Advance...

Amberstone Biosciences and Henlius Enter into Collaboration and License Agreement for Conditionally Activated T-Cell Engagers for Solid Tumors

IRVINE, Calif., Sept. 24, 2026 /PRNewswire/ -- Amberstone Biosciences, Inc., a preclinical-stage oncology company developing pH-gated, tumor-activated T-cell engagers (TCEs),...

error: Content is protected !!